Clinical efficacy of ursodeoxycholic acid in the comprehensive treatment of patients with obesity and gastroesophageal reflux disease
Background. Disorders in the body of patients with obesity have a systemic metabolic nature, including a negative impact on the state of the gastrointestinal tract. There was found a correlation between obesity and digestive diseases such as hepatic and pancreatic steatosis, gallstone disease, as we...
Main Author: | Ye.S. Sirchak |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House Zaslavsky
2018-11-01
|
Series: | Gastroenterologìa |
Subjects: | |
Online Access: | http://gastro.zaslavsky.com.ua/article/view/154140 |
Similar Items
-
Differentiation therapy for non-acidic gastroesophageal reflux disease
by: N B Lishchuk, et al.
Published: (2017-04-01) -
Gastroesophageal Reflux Disease and Alkaline Reflux: the Mechanisms of the Development and Therapeutic Approach
by: T.D. Zviahintseva, et al.
Published: (2016-11-01) -
The feasibility of using ursodeoxycholic acid in the treatment of patients with non-alcoholic fatty liver disease: a clinical case
by: Ye.S. Sirchak
Published: (2018-09-01) -
AIM. To evaluate the efficiency and safety of Livodexa monotherapy in patients with reflux esophagitis (RE) after gastric resection or gastrectomy.
by: O N Minushkin, et al.
Published: (2014-08-01) -
Changes in prostaglandin levels in the blood serum of patients with gastroesophageal reflux disease on the background of type 2 diabetes mellitus
by: Ye.S. Sirchak, et al.
Published: (2018-09-01)